Medical devices, healthcare technology and the business of care
PMA approval · P070004

SIENTRA SILICONE GEL BREAST IMPLANTS

Tiger Aesthetics Medical, LLC · Decision date Mar 9, 2012

FDA DECISIONP070004

What did the FDA approve?

FDA records P070004 as an original PMA application. The recorded decision is approval, dated Mar 9, 2012.

FDA approval order statement

APPROVAL FOR THE SIENTRA SILICONE GEL BREAST IMPLANTS. THIS DEVICE IS INDICATED FOR: 1) BREAST AUGMENTATION FOR WOMEN AT LEAST 22 YEARS OLD. BREAST AUGMENTATION INCLUDES PRIMARY BREAST AUGMENTATION AS WELL AS REVISION SURGERY TO CORRECT OR IMPROVE THE RESULT OF PRIMARY BREAST AUGMENTATION SURGERY; AND 2) BREAST RECONSTRUCTION. BREAST RECONSTRUCTION INCLUDES PRIMARY RECONSTRUCTION TO REPLACE BREAST TISSUE THAT HAS BEEN REMOVED DUE TO CANCER OR TRAUMA OR THAT HAS FAILED TO DEVELOP PROPERLY DUE TO A SEVERE BREAST ABNORMALITY. BREAST RECONSTRUCTION ALSO INCLUDES REVISION SURGERY TO CORRECT OR IMPROVE THE RESULTS OF A PRIMARY BREAST RECONSTRUCTION SURGERY.
Regulatory pathway
Original PMA
Clinical specialty
General, Plastic Surgery
Decision date
Mar 9, 2012

FDA source record

Regulatory record facts

Identifier
P070004
Regulatory pathway
Premarket approval application
Product code
FTR
Decision code
APPR
Decision date
Mar 9, 2012
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, breast, noninflatable, internal, silicone gel-filled.

Product code
FTR
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P070004 received

    Application receipt date recorded by FDA.

  2. P070004 · FDA decision

    APPR

  3. P070004/S049 · Related supplement

    Sientra Silicone Gel Breast Implants

Timeline entries are records held by MedtechLedger for P070004. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P070004

Product / regulatory recordCompanyPathwayDecision dateSource
Tiger Aesthetics Medical, LLCPMA supplementNov 4, 2026FDA

Explore the linked device profile

Other records with product code FTR

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Tiger Aesthetics Medical, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
9779 S. Franklin Dr., Suite 300, Franklin, WI, 53132

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records